T. Yamamura

发表

Probucol prevents lipid storage in macrophages.

S. Yokoyama, S. Takaichi, A. Yamamoto, 1986, Atherosclerosis.

Hyperlipoproteinemia as a risk factor for ischemic heart disease.

K. Haze, A. Yamamoto, K. Hiramori, 1990, Japanese circulation journal.

Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.

Y. Matsuzawa, S. Tarui, K. Kameda, 1984, Atherosclerosis.

Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia.

A. Yamamoto, T. Yamamura, Y. Toyota, 1994, Atherosclerosis.

Serum lipid levels in elementary and junior high school children and their relationship to relative weight.

Y. Matsuzawa, S. Yokoyama, A. Yamamoto, 1988, Preventive medicine.

Effects of probucol on xanthomata regression in familial hypercholesterolemia.

T. Funahashi, Y. Matsuzawa, S. Yokoyama, 1986, The American journal of cardiology.

Clinical features of familial hypercholesterolemia.

T. Funahashi, S. Yokoyama, T. Kamiya, 1989, Arteriosclerosis.

Intensive Drug Treatment for Familial Hypercholesterolemia

S. Yokoyama, A. Yamamoto, T. Yamamura, 1987 .

Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia.

S. Yokoyama, A. Yamamoto, T. Yamamura, 1985, Journal of biochemistry.

A point mutation of low-density-lipoprotein receptor causing rapid degradation of the receptor.

T. Funahashi, T Funahashi, A. Yamamoto, 1992, European journal of biochemistry.

A novel point mutation in a splice acceptor site of intron 1 of the human low density lipoprotein receptor gene which causes severe hypercholesterolemia: An unexpected absence of exon skipping

T. Funahashi, Y. Matsuzawa, T. Maruyama, 1998, Human mutation.

Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia.

A. Yamamoto, T. Yamamura, S. Tajima, 1988, Journal of biochemistry.

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

T. Sumiyoshi, A. Yamamoto, K. Hiramori, 1984, The Journal of clinical investigation.

Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein.

A. Yamamoto, T. Yamamura, S. Tajima, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Development of a homogeneous assay to measure remnant lipoprotein cholesterol.

S. Yamashita, T. Irie, M. Ishigami, 2007, Clinical chemistry.

Remnant lipoprotein-cholesterol is a predictive biomarker for large artery atherosclerosis in apparently healthy women: usefulness as a parameter for annual health examinations

S. Yamashita, M. Nishida, T. Moriyama, 2011, Annals of clinical biochemistry.

No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles.

W. Li, A. Gotto, L. Chan, 1991, American journal of human genetics.

Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency.

A. Yamamoto, H. Sudo, T. Yamamura, 1979, Atherosclerosis.

Triglyceride and glucose intolerance as a risk factor for coronary heart disease.

Y. Matsuzawa, A. Yamamoto, A. Kawaguchi, 1991, Cardiology.

Serum Lipid Levels in School Boys and Girls in Shinjo District

Y. Matsuzawa, S. Yokoyama, Y. Kawai, 1982 .

A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.

S. Kihara, T. Funahashi, I. Shimomura, 2010, Internal medicine.

Concentration and distribution of apolipoproteins A-I and E in normolipidemic, WHHL and diet-induced hyperlipidemic rabbit sera.

A. Yamamoto, H. Mezdour, T. Yamamura, 1992, Biochimica et biophysica acta.

A new isoform of apolipoprotein E--apo E-5--associated with hyperlipidemia and atherosclerosis.

A. Yamamoto, K. Hiramori, T. Yamamura, 1984, Atherosclerosis.

A Japanese family with high density lipoprotein deficiency.

S. Yokoyama, S. Tajima, A. Yamamoto, 1983, Atherosclerosis.

Genetic but not diet-induced hypercholesterolemia causes low apolipoprotein A-IV level in rabbit sera.

A. Yamamoto, H. Mezdour, T. Yamamura, 1995, Atherosclerosis.

Characterization of very low density lipoprotein from Watanabe heritable hyperlipidemic rabbits.

T. Kita, Y. Teranishi, M. Yokode, 1989, Journal of lipid research.

Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.

M. Harada‐Shiba, A. Yamamoto, A. Kawaguchi, 1997, Clinical science.

Escape phenomenon occurs by lowering cholesterol with a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor in patients with familial hypercholesterolemia.

S. Yokoyama, A. Yamamoto, T. Yamamura, 1988, Atherosclerosis.

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.

M. Ishigami, T. Minakata, T. Yamamura, 2011, Journal of atherosclerosis and thrombosis.

Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.

Y. Matsuzawa, S. Yokoyama, A. Yamamoto, 1984, International journal of clinical pharmacology, therapy, and toxicology.

Lipoprotein (a) in ischemic heart disease and cerebrovascular disease.

X. Yang, K. Haze, A. Yamamoto, 1995, Journal of atherosclerosis and thrombosis.

Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population.

T. Funahashi, Y. Matsuzawa, T. Maruyama, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Interaction between oligodendroglia and immune cells: Mitogenic effect of an oligodendrocyte precursor cell line on syngeneic T lymphocytes

H. Wekerle, T. Yamamura, F. Aloisi, 1992, Journal of neuroscience research.

Distribution of proteolipid protein and myelin basic protein in cultured mouse oligodendrocytes: Primary vs. secondary cultures

T. Yamamura, M. Lees, T. Yamamura, 1991, Journal of neuroscience research.

Characterization of apolipoprotein E7 (Glu(244)-->Lys, Glu(245)--->Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis.

A. Yamamoto, T. Yamamura, L. Dong, 1999, Journal of lipid research.

Orientation of the myelin proteolipid protein C‐terminus in oligodendroglial membranes

T. Yamamura, M. Lees, T. Yamamura, 1992, Glia.

Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase.

S. Yokoyama, R. Jackson, A. Yamamoto, 1986, Biochimica et biophysica acta.

Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.

J. Johnson, K. Shirai, R. Jackson, 1981, Metabolism: clinical and experimental.

Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.

V. Kuchroo, R. Sobel, M. Dorf, 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

Risk Factors for Atherosclerotic Vascular Diseases with Special Reference to the Relationship between Apolipoprotein E Mutations and Hyperlipidemia

S. Tajima, A. Yamamoto, T. Yamamura, 1990, Annals of the New York Academy of Sciences.

An extraskeletal osteosarcoma in an aged rat.

T. Yamamura, A. Okaniwa, K. Imaizumi, 1988, Nihon juigaku zasshi. The Japanese journal of veterinary science.

Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia.

M. Menju, A. Yamamoto, T. Yamamura, 1989, Journal of biochemistry.

Fatty Acid Composition of Phospholipids in Human Serum Lipoprotein Fractions

Y. Matsuzawa, A. Yamamoto, T. Yamamura, 1977 .

Regulatory Mechanism of Silkworm Hemocyte Adhesion to Organs

K. Iwabuchi, T. Satoh, Shinichirou Takahashi, 2011, Zoological science.

Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia.

C. Yutani, K. Miyatake, A. Yamamoto, 1999, American heart journal.

Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits.

A. Yamamoto, H. Mezdour, T. Yamamura, 1995, Atherosclerosis.

Acquisition of Secretion of Transforming Growth Factor-β1 Leads to Autonomous Suppression of Scavenger Receptor Activity in a Monocyte-Macrophage Cell Line, THP-1*

M. Harada‐Shiba, S. Tajima, A. Yamamoto, 1998, The Journal of Biological Chemistry.

Copper deficiency-induced pancytopenia after taking an excessive amount of zinc formulation during maintenance hemodialysis

S. Tanosaki, T. Yamamura, A. Marumo, 2021, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis

Manfred Stuhrmann, Hartmut Schmidt, Christophe Béroud, 1998, Nucleic Acids Res..

Electron microscopy of renal arterial lesion in a pup infected with canine herpes virus.

T. Yamamura, A. Okaniwa, Y. Minato, 1992, The Journal of veterinary medical science.

Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3----Lys) and its binding to low density lipoprotein receptors.

A. Yamamoto, T. Yamamura, S. Tajima, 1992, Biochemical and biophysical research communications.

Enhanced binding activity of an apolipoprotein E mutant, APO E5, to LDL receptors on human fibroblasts.

A. Yamamoto, T. Yamamura, L. Dong, 1990, Biochemical and biophysical research communications.

Genetic variants in PCSK9 in the Japanese population: rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population.

Y. Kokubo, T. Miyata, A. Okayama, 2008, Atherosclerosis.

Update of Japanese common LDLR gene mutations and their phenotypes: Mild type mutation L547V might predominate in the Japanese population.

Y. Kokubo, T. Miyata, N. Sakai, 2009, Atherosclerosis.

K. Kario, T. Miyata, A. Yamamoto, 1999, Thrombosis and Haemostasis.

Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a case-control study.

S. Yamashita, T. Funahashi, Y. Matsuzawa, 2001, Japanese circulation journal.

Spontaneous renal pelvic tumor in an aged rat.

T. Yamamura, A. Okaniwa, H. Yuasa, 1987, Nihon juigaku zasshi. The Japanese journal of veterinary science.

[Genetic mutants of plasma apolipoprotein E--apo E-5 and apo E-Suita--associated with hyperlipidemia and atherosclerosis].

S. Yokoyama, T. Sumiyoshi, A. Yamamoto, 1985, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Uptake of oxidized low-density lipoprotein in a THP-1 cell line lacking scavenger receptor A.

M. Harada‐Shiba, A. Yamamoto, T. Yamamura, 2001, Atherosclerosis.

Apolipoprotein E polymorphism and coronary heart disease.

A. Yamamoto, T. Yamamura, L. Dong, 1992, Chinese medical journal.

Rebound Curve Following LDL-Apheresis Reflects Catabolic Rate of Plasma Cholesterol And The Synthetic Rate of Lp(A)

M. Harada‐Shiba, A. Yamamoto, S. Kojima, 1996 .